News

Heska claimed that the VitalPath analyzer delivers accurate results in just 50 seconds for blood gases, electrolytes, and hematocrit, as well as 27 additional calculated parameters. Requiring just

Mr Mills joins Qualitest Pharma from Columbia Laboratories, where he was CEO and president. He previously held senior management positions at Watson Pharmaceuticals, Schein Pharmaceuticals and Alpharma. Marvin

The Supera Veritas system was developed by IDEV to deliver its self-expanding Supera interwoven nitinol stent, a novel stent platform designed for the treatment of biliary and peripheral

Muparfostat (PI-88) is one of a new class of multi-targeted cytostatic cancer therapeutics. It is a novel anti-cancer compound with a mechanism as a heparan sulfate mimetic. Muparfostat

Vaxon Biotech said that the Phase I/II trial was conducted among 116 patients with different types of cancer including 33 patients with NSCLC. The primary objective was to

Movianto is part of the Celesio, a healthcare distribution group. The group is active in 26 countries and employs more than 46,000 people in its three divisions patient

Eisai said that its 65,000sqft facility is expected to serve as Eisai’s global commercial manufacturing and drug development site for intravenous drug products in support of the company’s

Horizon Pharma said that the MONA (modified release prednisone for the treatment of nocturnal asthma) study is a two-stage, open-label, pilot trial assessing Lodotra’s treatment effect in patients

Following a detailed analysis of the efficacy and safety results from the RA programme, Roche and Biogen Idec have concluded that the overall benefit to risk profile of